in 2015, the company has built a portfolio of 20+ drug development programs ranging from preclinical to late-stage... development in multiple therapeutic areas including genetic dermatology, precision oncology, cardiology, endocrinology, neurology...
BridgeBioin 2015, the company has built a portfolio of 20+ drug development programs ranging from preclinical to late-stage... development in multiple therapeutic areas including genetic dermatology, precision oncology, cardiology, endocrinology, neurology...
BridgeBioprograms ranging from preclinical to late-stage development in multiple therapeutic areas including genetic dermatology... candidate, infigratinib, we seek to provide an option to children living with Achondroplasia and their families. Our business...
BridgeBioa portfolio of 30+ drug development programs ranging from preclinical to late-stage development in multiple therapeutic areas... the business and TMF needs across the entire Research & Development (R&D) organization of Eidos and BridgeBio...
BridgeBiodevelopment as well as reviewing scientific, clinical, and medical publications. Provide advice on legal business matters... processes. Its current clinical development pipeline consists of product candidates targeting hepatitis delta and hepatitis B...
Vir Biotechnologyin 2015, the company has built a portfolio of 20+ drug development programs ranging from preclinical to late-stage... proficient IT Systems Manager / Sr. Business Analyst passionate about supporting commercial and medical processes through...
BridgeBioprocesses. Its current clinical development pipeline consists of product candidates targeting hepatitis delta and hepatitis B... viruses and human immunodeficiency virus. Vir has several preclinical candidates in its pipeline, including those targeting...
Vir Biotechnology